Novo at the Easd Congress: New Treatment Prospects for Diabetes and Obesity
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.9 Articles
9 Articles
Sassuolo 2000
Quotidiano NazionaleNews Sassuolo - Sassuolo2000 daily online - news today sassuolo
Italpress is an Italian press agency of a national character. Managing Director Gaspare Borsellino. Editorial Director Italo Cucci.
(Adnkronos) " Value of innovation, clinical evidence and new therapeutic options. On these issues, on the occasion of the 62nd Easd Congress (European Association for the Study of Diabetes) in Milan, some of the leading clinical experts on diabetes and obesity took stock of the main novelties, in a meeting organized by Novo. Effectiveness, safety, [...]
(Adnkronos) " Value of innovation, clinical evidence and new therapeutic options. On these issues, on the occasion of the 62nd Easd Congress (European Association for the Study of Diabetes) in Milan, some of the leading clinical experts of diabetes and obesity took stock of the main novelties, in a meeting organized by Novo. Effectiveness, safety, [...] The article Novo at Easd Congress: "New prospects of cure for diabetes and obesity" comes fro…
(Adnkronos) " Value of innovation, clinical evidence and new therapeutic options. On these issues, at the 62nd Easd Congress (European Association for the Study of Diabetes) in Milan, some of the leading clinical experts on diabetes and obesity took stock of the main novelties, in a meeting organized by Novo. Effectiveness, safety, [...] The article Novo at Easd Congress: "New prospects of cure for diabetes and obesity" comes from Rec News.
newsbiella.it
Il Quotidiano del SudMILAN (ITALPRESS) - Value of innovation, clinical evidence and new therapeutic options. On these issues, at the 62nd EASD Congress, some of the leading clinical experts on the topics of diabetes and obesity have made the most...
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
